Literature DB >> 7086996

The etiology of detrusor hyperreflexia in patients with infravesical obstruction.

S A Chalfin, W E Bradley.   

Abstract

Bladder function was studied in 44 patients with bladder outlet obstruction by gas cystometry, integrated sphincter electromyography and uroflowmetry. Of these 44 patients 18 demonstrated detrusor hyperreflexia on cystometry. To identify the prostate as a possible source for triggering sensory stimuli pharmacologic ablation with lidocaine was performed through a perineal approach in 11 patients with hyperreflexia. Prostatic block eliminated hyperreflexia in 10 of 11 patients and had no effect in 4 patients with a normal cystometrogram. We believe that this study lends support to the concept that sensory stimuli from an anatomically altered prostatic urethra induces detrusor hyperreflexia. This suggests that permanent ablation of sensory stimuli from the prostate in patients with outlet obstruction would be of benefit.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7086996     DOI: 10.1016/s0022-5347(17)54139-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

1.  Persistent detrusor overactivity after transurethral resection of the prostate.

Authors:  Fadi Housami; Paul Abrams
Journal:  Curr Urol Rep       Date:  2008-07       Impact factor: 3.092

Review 2.  Neuronal nitric oxide synthase in the neural pathways of the urinary bladder.

Authors:  Y Zhou; E A Ling
Journal:  J Anat       Date:  1999-05       Impact factor: 2.610

Review 3.  Neural control of the lower urinary tract: peripheral and spinal mechanisms.

Authors:  L Birder; W de Groat; I Mills; J Morrison; K Thor; M Drake
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

4.  Efficacy of tolterodine in preventing urge incontinence immediately after prostatectomy.

Authors:  Dionisios Mitropoulos; Stefanos Papadoukakis; Anastasios Zervas; Christos Alamanis; Aris Giannopoulos
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

5.  Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator.

Authors:  Irina V Zabbarova; Youko Ikeda; Mark G Kozlowski; Pradeep Tyagi; Lori A Birder; Basu Chakrabarty; Subashan Kpg Perera; Rajiv Dhir; Adam C Straub; Peter Sandner; Karl-Erik Andersson; Marcus J Drake; Christopher H Fry; Anthony J Kanai
Journal:  J Pathol       Date:  2022-02-15       Impact factor: 9.883

Review 6.  Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Authors:  M I Wilde; A Fitton; D McTavish
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 7.  Place of overactive bladder in male lower urinary tract symptoms.

Authors:  Osamu Yamaguchi; Ken Aikawa; Keiichi Shishido; Masanori Nomiya
Journal:  World J Urol       Date:  2009-12       Impact factor: 4.226

8.  Why is transurethral microwave thermotherapy (TUMT) positively effective?

Authors:  T Sugiyama; Y C Park; T Hanai; N Ohnishi; T Kurita
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

9.  A possible link between stress urinary incontinence and detrusor instability in the female--urodynamic (pressure/flow) data and speculative considerations.

Authors:  A Cucchi
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

Review 10.  Overactive bladder in the male patient: bladder, outlet, or both?

Authors:  Khaled F Abdel-Aziz; Gary E Lemack
Journal:  Curr Urol Rep       Date:  2002-12       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.